Activation of NADPH oxidases leads to DNA damage in esophageal cells

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Bhardwaj, Vikas ^b   Gokulan, Ravindran Caspa ^b   Horvat, Andela ^b   Yermalitskaya, Liudmila ^b   Korolkova, Olga ^b   Washington, Kay M ^d   El Rifai, Wael ^b,c   Dikalov, Sergey I ^d   Zaika, Alexander I ^a,b,c  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CYBB PROTEIN, HUMAN; NOX1 PROTEIN, HUMAN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2;

BARRETT ESOPHAGUS; CELL CULTURE; DNA DAMAGE; EPITHELIUM CELL; HUMAN; METABOLISM; PATHOLOGY;

BARRETT ESOPHAGUS; BILE ACIDS AND SALTS; CELLS, CULTURED; DNA DAMAGE; EPITHELIAL CELLS; HUMANS; NADPH OXIDASE 1; NADPH OXIDASE 2; REACTIVE OXYGEN SPECIES;

EID: 85028593334     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-09620-4     Document Type: Article

References (37)

1. Shaheen, N. & Provenzale, D. The epidemiology of gastroesophageal reflux disease. Am J Med Sci 326, 264-273 (2003).
2. Shaheen, N. J. & Richter, J. E. Barrett's oesophagus. Lancet 373, 850-861 (2009).
3. Souza, R. F. Molecular and biologic basis of upper gastrointestinal malignancy-esophageal carcinoma. Surg Oncol Clin N Am 11, 257-272, viii (2002).
4. McQuaid, K. R., Laine, L., Fennerty, M. B., Souza, R. & Spechler, S. J. Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia. Aliment Pharmacol Ther 34, 146-165, doi: 10.1111/j.1365-2036.2011.04709.x (2011).
5. Theisen, J. et al. The mutagenic potential of duodenoesophageal reflux. Ann Surg 241, 63-68 (2005).
6. Fu, X. et al. cAMP-response element-binding protein mediates acid-induced NADPH oxidase NOX5-S expression in Barrett esophageal adenocarcinoma cells. J Biol Chem 281, 20368-20382, doi: 10.1074/jbc.M603353200 (2006).
7. Hong, J., Li, D., Wands, J., Souza, R. & Cao, W. Role of NADPH oxidase NOX5-S, NF-kappaB, and DNMT1 in acid-induced p16 hypermethylation in Barrett's cells. Am J Physiol Cell Physiol 305, C1069-1079, doi: 10.1152/ajpcell.00080.2013 (2013).
8. Li, D. & Cao, W. Role of intracellular calcium and NADPH oxidase NOX5-S in acid-induced DNA damage in Barrett's cells and Barrett's esophageal adenocarcinoma cells. Am J Physiol Gastrointest Liver Physiol 306, G863-872, doi: 10.1152/ajpgi.00321.2013 (2014).
9. Li, D. & Cao, W. Bile acid receptor TGR5, NADPH Oxidase NOX5-S and CREB Mediate Bile Acid-Induced DNA Damage In Barrett's Esophageal Adenocarcinoma Cells. Sci Rep 6, 31538, doi: 10.1038/srep31538 (2016).
10. Dvorak, K. et al. Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus. Gut 56, 763-771 (2007).
11. Boeckxstaens, G. E. & Smout, A. Systematic review: role of acid, weakly acidic and weakly alkaline reflux in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 32, 334-343 (2010).
12. Nehra, D., Howell, P., Williams, C. P., Pye, J. K. & Beynon, J. Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity. Gut 44, 598-602 (1999).
13. Bhardwaj, V. et al. Prevention of DNA damage in Barrett's esophageal cells exposed to acidic bile salts. Carcinogenesis 37, 1161-1169, doi: 10.1093/carcin/bgw100 (2016).
14. Feagins, L. A. et al. Mechanisms of oxidant production in esophageal squamous cell and Barrett's cell lines. Am J Physiol Gastrointest Liver Physiol 294, G411-417 (2008).
15. Huo, X. et al. Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-kappaB activation in benign Barrett's epithelial cells. Am J Physiol Gastrointest Liver Physiol 301, G278-286, doi: 10.1152/ajpgi.00092.2011 (2011).
16. Gillissen, A. & Nowak, D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. Respir Med 92, 609-623 (1998).
17. Marciniak, A. et al. Tempol, a Membrane-Permeable Radical Scavenger, Exhibits Anti-Inflammatory and Cardioprotective Effects in the Cerulein-Induced Pancreatitis Rat Model. Oxid Med Cell Longev 2016, 4139851, doi: 10.1155/2016/4139851 (2016).
18. Petronio, M. S., Zeraik, M. L., Fonseca, L. M. & Ximenes, V. F. Apocynin: chemical and biophysical properties of a NADPH oxidase inhibitor. Molecules 18, 2821-2839, doi: 10.3390/molecules18032821 (2013).
19. Dikalova, A. E. et al. Therapeutic targeting of mitochondrial superoxide in hypertension. Circ Res 107, 106-116, doi: 10.1161/CIRCRESAHA.109.214601 (2010).
20. El-Benna, J., Dang, P. M., Gougerot-Pocidalo, M. A., Marie, J. C. & Braut-Boucher, F. p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases. Exp Mol Med 41, 217-225, doi: 10.3858/emm.2009.41.4.058 (2009).
21. Ambasta, R. K., Schreiber, J. G., Janiszewski, M., Busse, R. & Brandes, R. P. Noxa1 is a central component of the smooth muscle NADPH oxidase in mice. Free Radic Biol Med 41, 193-201, doi: 10.1016/j.freeradbiomed.2005.12.035 (2006).
22. Niu, X. L. et al. Nox activator 1: a potential target for modulation of vascular reactive oxygen species in atherosclerotic arteries. Circulation 121, 549-559, doi: 10.1161/CIRCULATIONAHA.109.908319 (2010).
23. Takeya, R. et al. Novel human homologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases. J Biol Chem 290, 6003, doi: 10.1074/jbc.A114.212856 (2015).
24. Makni-Maalej, K. et al. Zymosan induces NADPH oxidase activation in human neutrophils by inducing the phosphorylation of p47phox and the activation of Rac2: involvement of protein tyrosine kinases, PI3Kinase, PKC, ERK1/2 and p38MAPkinase. Biochem Pharmacol 85, 92-100, doi: 10.1016/j.bcp.2012.10.010 (2013).
25. Reinehr, R., Becker, S., Eberle, A., Grether-Beck, S. & Haussinger, D. Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J Biol Chem 280, 27179-27194, doi: 10.1074/jbc.M414361200 (2005).
26. Johnson, J. et al. A conventional protein kinase C inhibitor targeting IRF-3-dependent genes differentially regulates IL-12 family members. Mol Immunol 48, 1484-1493, doi: 10.1016/j.molimm.2011.04.006 (2011).
27. Miyashita, T. et al. Do proton pump inhibitors protect against cancer progression in GERD? Surg Today 43, 831-837, doi: 10.1007/s00595-012-0395-2 (2013).
28. Gimenez, M., Schickling, B. M., Lopes, L. R. & Miller, F. J. Jr. Nox1 in cardiovascular diseases: regulation and pathophysiology. Clin Sci (Lond) 130, 151-165, doi: 10.1042/CS20150404 (2016).
29. Stefanska, J. & Pawliczak, R. Apocynin: molecular aptitudes. Mediators Inflamm 2008, 106507, doi: 10.1155/2008/106507 (2008).
30. Bedard, K. & Krause, K. H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87, 245-313, doi: 10.1152/physrev.00044.2005 (2007).
31. Le, M. et al. Bile acids stimulate PKCalpha autophosphorylation and activation: role in the attenuation of prostaglandin E1-induced cAMP production in human dermal fibroblasts. Am J Physiol Gastrointest Liver Physiol 291, G275-287, doi: 10.1152/ajpgi.00346.2005 (2006).
32. McFadden, P. N., Mandpe, A. & Koshland, D. E. Jr. Calcium- and lipid-independent protein kinase C autophosphorylation. Activation by low pH. J Biol Chem 264, 12765-12771 (1989).
33. Rafiee, P. et al. Effect of curcumin on acidic pH-induced expression of IL-6 and IL-8 in human esophageal epithelial cells (HET-1A): role of PKC, MAPKs, and NF-kappaB. Am J Physiol Gastrointest Liver Physiol 296, G388-398, doi: 10.1152/ajpgi.90428.2008 (2009).
34. Jaiswal, K. R. et al. Characterization of telomerase-immortalized, non-neoplastic, human Barrett's cell line (BAR-T). Dis Esophagus 20, 256-264 (2007).
35. Wei, J. et al. Pathogenic bacterium Helicobacter pylori alters the expression profile of p53 protein isoforms and p53 response to cellular stresses. Proc Natl Acad Sci USA 109, E2543-2550, doi: 10.1073/pnas.1205664109 (2012).
36. Zaika, E. et al. p73 protein regulates DNA damage repair. Faseb J 25, 4406-4414 (2011).
37. Vilgelm, A. et al. DeltaNp73alpha regulates MDR1 expression by inhibiting p53 function. Oncogene 27, 2170-2176, doi: 10.1038/sj.onc.1210862 (2008).